Journals / European Journal of Therapeutics / 2019 / Cilt: 25 - Sayı: 3

Effcts of Regular Follow-up on Quality of Life and Warfarin Effiency in Rural Patients

Pages
183–188
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The median TTR during the follow-up increased significantly compared with the previous year [40.0 (IQR 36.5) vs. 62.1 (IQR 29.3); p70% increased significantly (36.8% vs. 21.1%, respectively; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to evaluate the effects of regular follow-up and education on warfarin efficiency, satisfaction, and thequality of life in patients from rural areas.Methods: A total of 133 patients from rural areas taking warfarin were followed up for the mean of 17.4±0.5 months (mean age58±13 years, 72.9% female).
📊
Key Findings & Data:A list and an illustratedbooklet presenting foods that interact with warfarin and a follow-up chart were prepared for each patient.
💡
Conclusion & Impact:The median TTR during the follow-up increased significantly compared with the previous year [40.0 (IQR 36.5) vs. 62.1 (IQR 29.3); p70% increased significantly (36.8% vs. 21.1%, respectively; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aims to evaluate the effects of regular follow-up and education on warfarin efficiency, satisfaction, and thequality of life in patients from rural areas.Methods: A total of 133 patients from rural areas taking warfarin were followed up for the mean of 17.4±0.5 months (mean age58±13 years, 72.9% female). All patients were educated and followed up by a single cardiologist prospectively. A list and an illustratedbooklet presenting foods that interact with warfarin and a follow-up chart were prepared for each patient. An illustrated scheme ofpills that were to be taken every day was prepared for illiterate patients. The international normalized ratio (INR) values during and1 year before the study were recorded from the hospital system, and the time in therapeutic range (TTR) was calculated. The DukeAnticoagulation Satisfaction Scale was conducted at the start and end of the study to determine patients’ satisfaction with warfarinuse. Furthermore, the Medical Outcomes Study Form 36 (SF-36) was used for determining the health-related quality of life (HRQoL).Results: A total of 45.9% of patients were illiterate, and 33.8% were primary school graduates. The median TTR during the follow-up increased significantly compared with the previous year [40.0 (IQR 36.5) vs. 62.1 (IQR 29.3); p70% increased significantly (36.8% vs. 21.1%, respectively; p

🔖

Cite This Article

ÇEKİCİ, Y., KILIÇ, S., SARAÇOĞLU, E., KILIÇ, D. D., YILDIRIM, A., KUZU, Z. (2022). Effcts of Regular Follow-up on Quality of Life and Warfarin Effiency in Rural Patients. European Journal of Therapeutics, Cilt: 25 - Sayı: 3, 183–188. https://ajindex.com/articles/512274

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial firillation. Eur Heart J 2012
  2. [CrossRef] 2. Turk UO, Tuncer E, Alioglu E, Yuksel K, Pekel N, Ozpelit E, et al. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial firillation in Turkey: Perspectives from the observational, prospective WATER Registry. Cardiol J 2015
  3. [CrossRef] 3. Ertaş F, Kaya H, Kaya Z, Bulur S, Köse N, Gül M, et al. Epidemiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER study. Turk Kardiyol Dern Ars 2013
  4. [CrossRef] 4. Çelik A, İzci S, Kobat MA, Ateş AH, Çakmak A, Çakıllı Y, et al. The awareness, efficy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR. Anatol J Cardiol 2016
  5. [CrossRef] 5. Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother 2003
  6. [CrossRef] 6. Casais P, Meschengieser S, Sanchez-Luceros A, Lazzari M. Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life. Curr Med Res Opin 2005
  7. [CrossRef] 7. Samsa G, Matchar DB, Dolor RJ, Wiklund I, Hedner E, Wygant G, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes 2004
  8. [CrossRef] 8. Tokgözoğlu L, Oğuz A, Balcı MK, Temizhan A, Altunoğlu EG, Bektaş O, et al. Turkish assessment of SURF (SUrvey of Risk Factor Management) study: Control rates of cardiovascular risk factors derived from databases of 15 diffrent levels of health centers in Turkey. Turk Kardiyol Dern Ars 2017
  9. Rosendaal F, Cannegieter S, van der Meer F, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993
  10. [CrossRef] 10. Samsa G, Matchar DB, Dolor RJ, Wiklund I, Hedner E, Wygant G, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes 2004
  11. [CrossRef] 11. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988
  12. [CrossRef] 12. Yıldırım JG, Temel AB. Duke antikoagülan memnuniyet ölçeğinin Tü